Back
Live market summary

Before Jan 20, 2029 is favored at 49% as of 4 Oct 2026, 05:04 UTC across 3 markets.

  • Before Jan 20, 2029: 49% (24h change 0%)
  • Before Jan 1, 2028: 29% (24h change 0%)
  • Before Jan 1, 2027: 11% (24h change 0%)
policy3 marketsLIVE

When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

Trade ↗

Odds history

Loading chart

All options

About this market

Market question: When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

How to read these odds

Each percentage is the latest traded Kalshi price for that option. A 62% contract price implies a 62% market-estimated chance, but prediction markets can move quickly and are not polls.

Market odds FAQ

Who is favored in When will CMS announce the addition of GLP-1 drugs for obesity to Par?

Before Jan 20, 2029 is favored at 49% as of 4 Oct 2026, 05:04 UTC, based on live Kalshi prediction-market prices.

What are the current odds for When will CMS announce the addition of GLP-1 drugs for obesity to Par?

Before Jan 20, 2029: 49%; Before Jan 1, 2028: 29%; Before Jan 1, 2027: 11%. These are live market prices.

Where do these odds come from?

Each probability is a traded price from Kalshi, a CFTC-regulated prediction-market exchange. A contract trading at 62¢ implies a 62% market-estimated chance. ElectionOdds displays the data and does not create its own forecast.